Haemonetics (HAE) Tops Q4 EPS by 6c, Offers Guidance, Approves $500M Buyback
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/13/2026
- Tech stocks power S&P 500 to record high as oil, producer inflation weaken
- Oil falls more than 3% on weaker global demand outlook and US crude buildup
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
- After-Hours Movers: CSCO, COHR, HLIT, CBRS, STUB, ENS
- After-Hours Movers: CRWV, NBIS, SMCI, LITE, CAVA, HRB
- After-Hours Movers: P, RIOT, BW, RKLB, HIMS, UPWK
- After-Hours Movers: TEAM, NET, TWLO, DOCS, FROG, DV, TTD, ABNB, DKNG, SG, RKT
- After-Hours Stock Movers: WDC, SNDK, FIG, APP, HUBS, SOUN, DASH, XYZ, Z, FLNC
Haemonetics 4th Quarter and Fiscal 2019 Earnings Release Available on Investor Relations Website
May 7, 2019 6:10 AM EDTBRAINTREE, Mass., May 7, 2019 /PRNewswire/ --Â Haemonetics Corporation (NYSE: HAE) announced that financial results for its fourth quarter and fiscal year ended March 30, 2019 are available on its Investor relations website.
... More